• This record comes from PubMed

Ribonucleases endowed with specific toxicity for spermatogenic layers

. 1997 Dec ; 118 (4) : 881-888.

Status PubMed-not-MEDLINE Language English Country Great Britain, England Media print

Document type Journal Article

Grant support
R01 CA073808 NCI NIH HHS - United States
T32 GM007215 NIGMS NIH HHS - United States

Bovine seminal ribonuclease (BS-RNase) is a dimer in which the subunits are cross-linked by disulfide bonds between Cys31 of one subunit and Cys32 of the other. Dimeric BS-RNase is resistant to ribonuclease inhibitor (RI), a protein endogenous to mammalian cells, and is toxic to a variety of cell types. Monomeric BS-RNase (like its homolog, RNase A) is bound tightly by RI and is not cytotoxic. The three-dimensional structure of the RI·RNase A complex suggests that carboxymethylation of C32S BS-RNase (to give MCM31) or C31S BS-RNase (MCM32) could diminish affinity for RI. We find that MCM31 and MCM32 are not only resistant to RI, but are also aspermatogenic to mice. In contrast to the aspermatogenic activity of dimeric BS-RNase, that of MCM31 and MCM32 is directed only at spermatogenic layers. Intratesticular injection of MCM31 or MCM32 affects neither the diameter of seminiferous tubules nor the weight of testes. Also in contrast to wild-type BS-RNase, MCM31 and MCM32 are not toxic to other cell types. Direct immunofluorescence reveals that MCM31 and MCM32 bind only to spermatogonia and primary spermatocytes. This cell specificity makes MCM31 and MCM32 of potential use in seminoma therapy and contraception.

See more in PubMed

Ardelt W, Mikulski SM, Shogen K. Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. J. Biol. Chem. 1991;266:245–251. PubMed

Bartholeyns J, Baudhuin P. Inhibition of tumor cell proliferation by dimerized ribonuclease. Proc. Natl. Acad. Sci. USA. 1976;73:573–576. PubMed PMC

Bartholeyns J, Zenebergh A. In vitro and in vivo antitumor effect of dimerized ribonuclease A. Eur. J. Cancer. 1979;15:85–91. PubMed

Beintema JJ, Schüller C, Irie M, Carsana A. Molecular evolution of the ribonuclease superfamily. Prog. Biophys. Molec. Biol. 1988;51:165–192. PubMed

Blackburn P, Gavilanes JG. Identification of lysine residues in the binding domain of ribonuclease A for the RNase inhibitor from human placenta. J. Biol. Chem. 1982;255:10959–10965. PubMed

Blackburn P, Moore S. Pancreatic ribonuclease. The Enzymes. 1982;XV:317–433.

Cafaro B, De Lorenzo C, Piccoli R, Bracale A, Mastronicola MR, Di Donato A, D'Alessio G. The antitumor action of seminal ribonuclease and its quaternary conformations. FEBS Lett. 1995;359:31–34. PubMed

Clouthier DE, Avarbock MR, Maika SD, Hammer RE, Brinster RL. Rat spermatogenesis in mouse testis. Nature. 1996;381:418–421. PubMed PMC

D'Alessio G. New and cryptic biological messages from RNases. Trends Cell Biol. 1993;3:106–109. PubMed

D'Alessio G, Di Donato A, Parente A, Piccoli R. Seminal RNase: a unique member of the ribonuclease superfamily. Trends Biochem. Sci. 1991;16:106–108. PubMed

D'Alessio G, Malorni MC, Parente A. Dissociation of bovine seminal ribonuclease into catalytically active monomers by selective reduction and alkylation of the intersubunit disulfide bridges. Biochemistry. 1975;14:1116–1122. PubMed

Di Donato A, Cafaro V, D'Alessio G. Ribonuclease A can be transformed into a dimeric ribonuclease with antitumor activity. J. Biol. Chem. 1994;269:17394–17396. PubMed

Di Donato A, Cafaro V, Romeo I, D'Alessio G. Hints on the evolutionary design of a dimeric RNase with special bioactions. Protein Sci. 1995;4:1470–1477. PubMed PMC

Dostál J, Matoušek J. Isolation and some chemical properties of aspermatogenic substance form bull seminal vesicle fluid. J. Reprod. Fertil. 1973;33:263–274. PubMed

Dostál J, Matoušek J. Purification of aspermatogenic substance (AS) from the bull seminal vesicle fluid. J. Reprod. Fert. 1972;31:273–275. PubMed

Elbe JN. Spermatocytic seminoma. Hum. Pathol. 1994;25:1035–1042. PubMed

Floridi A, D'Alessio G. Compartamento chromatografico della ribonucleasi seminale. Bull. Soc. Ital. Biol. Sper. 1967;43:32–36. PubMed

Harper JW, Vallee BL. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry. 1989;28:1875–1884. PubMed

Hlinák A, Matoušek J, Madlafoušek J. The effect of bull seminal ribonuclease on reproductive organs and sexual behaviour in male rats. Physiol. Bohem. 1981;30:539–542. PubMed

Hofsteenge J. “Holy” proteins I: ribonuclease inhibitor. Current Opin. Struct. Biol. 1994;4:807–809. PubMed

Kim J-S. Ph.D. Thesis. University of Wisconsin–Madison; 1994.

Kim J-S, Raines RT. Bovine seminal ribonuclease produced from a synthetic gene. J. Biol. Chem. 1993;268:17392–17396. PubMed

Kim J-S, Souček J, Matoušek J, Raines RT. Catalytic activity of bovine seminal ribonuclease is essential for its immunosuppressive and other biological activities. Biochem. J. 1995;308:547–550. PubMed PMC

Kim J-S, Souček J, Matoušek J, Raines RT. Mechanism of ribonuclease cytotoxicity. J. Biol. Chem. 1995;270:31097–31102. PubMed

Kim J-S, Souček J, Matoušek J, Raines RT. Structural basis for the biological activities of bovine seminal ribonuclease. J. Biol. Chem. 1995;270:10525–10530. PubMed

Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature. 1995;374:183–186. PubMed

Kraft N, Shortman K. A suggested control function for the animal tissue ribonuclease – ribonuclease inhibitor system, based on studies of isolated cells and phytohaemagglutinin-transformed lymphocytes. Biochim. Biophys. Acta. 1970;217:164–175. PubMed

Kyner D, Christman JK, Acs G. The effect of 12-O-tetradecanoyl-phorbol 13-acetate on the ribonuclease activity of circulating human lymphocytes. Eur. J. Biochem. 1979;99:395–399. PubMed

Lee FS, Vallee BL. Structure and action of mammalian ribonuclease (angiogenin) inhibitor. Progr. Nucl. Acid Res. Mol. Biol. 1993;44:1–30. PubMed

Leone E, Greco L, Rastogi RK, Ieala L. Antispermatogenic properties of bull seminal ribonuclease. J. Reprod. Fert. 1973;34:197–200. PubMed

Markham R, Smith JD. The structure of ribonucleic acids. 1. Cyclic nucleotides produced by ribonuclease and by alkaline hydrolysis. Biochem. J. 1952;52:552–557. PubMed PMC

Matoušek J. Aspermatogenic effect of the bull seminal ribonuclease (BS RNase) in the presence of anti BS RNase antibodies in mice. Animal Genet. 1994;25(Suppl. 1):45–50. PubMed

Matoušek J, D'Alessio G. Bull seminal ribonuclease (BS RNase), its immunosuppressive and other biological effects—a review. Anim. Sci. Papers Rep. 1991;7:5–14.

Matoušek J, Grozdanovic J. Specific effect of bull seminal ribonuclease (AS RNase) on cell systems in mice. Comp. Biochem. Physiol. 1973;46A:241–248. PubMed

Matoušek J, Pavlok A, Dostál J, Grozdanovic J. Some biological properties of bull seminal vesicle aspermatogenic substance and its effect on mice. J. Reprod. Fert. 1973;34:9–22. PubMed

Matoušek J, Souček J, Rìha J, Zankel TR, Benner SA. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Comp. Biochem. Physiol. 1995;112B:235–241. PubMed

Matoušek J, Souček J, Stratil A, Vallee BL. Immunosuppressive activity of angiogenin. Anim. Genet. Suppl. 1992;23:46.

Matoušek J, Stanek R. Action of bull seminal vesicle ribonuclease on mouse leukaemic cells. Folia Biol. (Prague) 1977;23:56–65. PubMed

Mazzarella L, Mattia CA, Capasso S, Di Lorenzo G. Composite active sites in bovine seminal ribonuclease. Gaz. Chim. Ital. 1987;117:91–97.

Messmore JM, Fuchs DN, Raines RT. Ribonuclease A: revealing structure–function relationships with semisynthesis. J. Am. Chem. Soc. 1995;117:8057–8060. PubMed PMC

Murthy BS, De Lorenzo C, Piccoli R, D'Alessio G, Sirdeshmukh R. Effects of protein RNase inhibitor and substrate on the quaternary structures of bovine smeinal RNase. Biochemistry. 1996;35:3880–3885. PubMed

Murthy BS, Sirdeshmukh R. Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor. Biochem. J. 1992;281:343–348. PubMed PMC

Rabes HM. Proliferation of human testicular tumours. Int. J. Androl. 1987;10:127–137. PubMed

Raines RT, Toscano MP, Nierengarten DM, Ha JH, Auerbach R. Replacing a surface loop endows ribonuclease A with angiogenic activity. J. Biol. Chem. 1995;270:17180–17184. PubMed

Roth JS. Some observations on the assay and properties of ribonucleases in normal and tumor tissues. Methods Cancer Res. 1967;3:153–242.

Russell LD, Ettlin RA, Hikim AP, Clegg ED. Histological and histopathological evaluation of the testis. Cache River Press; Clearwater, FL: 1990.

Shapiro R, Vallee BL. Interaction of human placental ribonuclease with placental ribonuclese inhibitor. Biochemistry. 1991;30:2246–2255. PubMed

Souček J, Chudomel V, Potmesilova I, Novak JT. Effect of ribonucleases on cell-mediated lympholysis reaction and on cfv-c colonies in bone marrow culture. Nat. Immun. Cell Growth Regul. 1986;5:250–258. PubMed

Souček J, Marinov I, Benes J, Hilgert I, Matoušek J, Raines RT. Immunosuppressive activity of bovine seminal ribonuclease and its mode of action. Immunobiology. 1996;195:271–285. PubMed

Souček J, Matousek J, Chudomel V, Lindnerová G. Inhibitory effect of bovine seminal ribonuclease on activated lymphocytes and lymphoblastoid cell lines in vitro. Folia Biol. (Prague) 1981;27:344–335. PubMed

Thompson JE, Venegas FD, Raines RT. Energetics of catalysis by ribonucleases: fate of the 2′,3′-cyclic intermediate. Biochemistry. 1994;33:7408–7414. PubMed

Wu Y, Mikulski SM, Ardelt W, Rybak SM, Youle RJ. A cytotoxic ribonuclease. J. Biol. Chem. 1993;268:10686–10693. PubMed

Wu Y, Saxena SK, Ardelt W, Gadina M, Mikulski SM, De Lorenzo V, D'Alessio G, Youle RJ. A study of the intracellular routing of cytotoxic ribonucleases. J. Biol. Chem. 1995;270:17476–17481. PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...